Product Details:
| Composition | Fluticasone Furoate (100mcg) + Umeclidinium (62.5mcg) + Vilanterol (25mcg) |
| Strength | 200 mcg |
| Device Type | Dry Powder |
| Brand | Trelegy Ellipta 100 MCG/62.5 MCG/25 MCG |
| Packaging Size | 1.0 Inhaler in 1 box |
| Treatment | Treatment of Chronic obstructive pulmonary disease (COPD) |
| Marketer | Glaxo SmithKline Pharmaceuticals Ltd |